3 Top AI-Powered Biotech Stocks to Buy in February
Artificial intelligence (AI) is transforming various industries as a major investing theme in 2025. The technology's ability ...
With uncertainty roiling Big Pharma, execs are placing lower-risk bets
The market has been no less demanding for pharma giants as 2025 begins, but last year’s strategies are paying off.
AbbVie secures $3 billion credit facility, total access now $8 billion
AbbVie Inc . (NYSE:ABBV), a Delaware-incorporated pharmaceutical company with a market capitalization of $339 billion and annual revenue exceeding $56 billion, has entered into a $3 billion unsecured ...
Jim Cramer Says AbbVie Inc. (ABBV) Is A ‘Buy’
We recently compiled a list of the Jim Cramer Shed Light on These 8 Stocks Recently. In this article, we are going to take a ...
FiercePharma23h
TV drug ad spending reached new heights in January, as Novartis' Pluvicto toppled AbbVie's Skyrizi for top spot
AbbVie’s Skyrizi was responsible for the highest TV advertising outlay in pharma in most months of 2024, but 2025 is starting ...